These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 2088187
1. Comparative in vitro and in vivo activities of six new monofluoroquinolone and difluoroquinolone 3-carboxylic acids with a 7-azetidin ring substituent. Gargallo-Viola D, Esteve M, Moros M, Coll R, Xicota MA, de Andres C, Roser R, Guinea J. Antimicrob Agents Chemother; 1990 Dec; 34(12):2318-26. PubMed ID: 2088187 [Abstract] [Full Text] [Related]
2. Antibacterial activities and pharmacokinetics of E-4767 and E-5065, two new 8-chlorofluoroquinolones with a 7-azetidin ring substituent. Gargallo-Viola D, Ferrer S, Tudela E, Robert M, Coll R, Roser R, Guinea J. Antimicrob Agents Chemother; 2001 Nov; 45(11):3113-21. PubMed ID: 11600365 [Abstract] [Full Text] [Related]
3. E-4695, a new C-7 azetidinyl fluoronaphthyridine with enhanced activity against gram-positive and anaerobic pathogens. Guinea J, Gargallo-Viola D, Robert M, Tudela E, Xicota MA, Garcia J, Esteve M, Coll R, Pares M, Roser R. Antimicrob Agents Chemother; 1995 Feb; 39(2):413-21. PubMed ID: 7726507 [Abstract] [Full Text] [Related]
4. In vitro and in vivo antibacterial activities of E-4497, a new 3-amine-3-methyl-azetidinyl tricyclic fluoroquinolone. Gargallo-Viola D, Esteve M, Llovera S, Roca X, Guinea J. Antimicrob Agents Chemother; 1991 Mar; 35(3):442-7. PubMed ID: 2039195 [Abstract] [Full Text] [Related]
5. In vitro and in vivo antibacterial activities of E-4868, a new fluoroquinolone with a 7-azetidin ring substituent. Guinea J, Robert M, Gargallo-Viola D, Xicota MA, Garcia J, Tudela E, Esteve M, Coll R, Pares M, Roser R. Antimicrob Agents Chemother; 1993 Apr; 37(4):868-74. PubMed ID: 8388202 [Abstract] [Full Text] [Related]
11. In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin. Mirelis B, Navarro F, Miró E, Coll R, Xicota MA, Prats G. Drugs Exp Clin Res; 1995 May; 21(4):129-38. PubMed ID: 8529525 [Abstract] [Full Text] [Related]
12. In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone. Nakamura S, Minami A, Nakata K, Kurobe N, Kouno K, Sakaguchi Y, Kashimoto S, Yoshida H, Kojima T, Ohue T. Antimicrob Agents Chemother; 1989 Aug; 33(8):1167-73. PubMed ID: 2802544 [Abstract] [Full Text] [Related]
13. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone. Robbins MJ, Baskerville AJ, Sanghrajka M, Mumtaz G, Felmingham D, Ridgway GL, Grüneberg RN. Diagn Microbiol Infect Dis; 1989 Aug; 12(3 Suppl):65S-76S. PubMed ID: 2791500 [Abstract] [Full Text] [Related]
15. In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin. Fung-Tomc J, Minassian B, Kolek B, Washo T, Huczko E, Bonner D. J Antimicrob Chemother; 2000 Apr; 45(4):437-46. PubMed ID: 10747819 [Abstract] [Full Text] [Related]
16. Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinolone. Visser MR, Rozenberg-Arska M, Beumer H, Hoepelman IM, Verhoef J. Antimicrob Agents Chemother; 1991 May; 35(5):858-68. PubMed ID: 1854167 [Abstract] [Full Text] [Related]
17. The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin. King A, Bethune L, Phillips I. J Antimicrob Chemother; 1991 Nov; 28(5):719-25. PubMed ID: 1663930 [Abstract] [Full Text] [Related]
18. A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria. Fernandes PB, Chu DT, Swanson RN, Ramer NR, Hanson CW, Bower RR, Stamm JM, Hardy DJ. Antimicrob Agents Chemother; 1988 Jan; 32(1):27-32. PubMed ID: 3348609 [Abstract] [Full Text] [Related]